Sarepta Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sarepta Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Sarepta Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $124M, a 7.96% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $124M -$10.7M -7.96% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $126M +$64.3M +104% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $130M +$65M +100% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $133M +$90.4M +210% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $135M +$87.7M +187% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $62M +$16M +34.9% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $65M +$19.4M +42.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $43M -$29.6M -40.8% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $47M -$25.9M -35.5% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $46M -$19.1M -29.3% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $45.5M -$46.2M -50.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $72.7M +$1.58M +2.22% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $72.9M -$1.33M -1.79% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $65.1M +$1.97M +3.12% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $91.8M +$53.8M +142% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $71.1M +$31.6M +80% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $74.2M +$34.7M +88.1% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $63.1M +$22M +53.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $37.9M -$4.57M -10.7% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $39.5M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $39.4M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $41.1M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $42.5M Jan 1, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.